Showing 721 - 734 results of 734 for search '"RNA"', query time: 0.10s Refine Results
  1. 721
  2. 722

    Whole-Body Regeneration Methods and Protocols /

    Published 2022
    Table of Contents: “…-Studying Tunicata WBR using Botrylloides anceps -- In Situ Hybridization to Identify Stem Cells in the Freshwater Sponge Ephydatia fluviatilis -- Isolation and Maintenance of In Vitro Cell Cultures from the Ctenophore Mnemiopsis leidyi -- Analysis of Spatial Gene Expression at the Cellular Level in Stony Corals -- Studying Stem Cell Biology in Intact and Whole-Body Regenerating Hydra by Flow Cytometry -- Non-Invasive Intra-Vascular Micro-Transfusion in Colonial Tunicates -- Gene Manipulation in Hydractinia -- Manipulation of Gene Activity in the Regenerative Model Sea Anemone, Nematostella vectensis -- Monitoring Telomere Maintenance during Regeneration of Annelids -- Analysis of DNA Double Stranded Breaks using the COMET Assay in Planarians -- Random Integration Transgenesis in a Free-Living Regenerative Flatworm Macrostomum lignano -- RNAi Screening to Assess Tissue Regeneration in Planarians -- Monitoring Chromatin Regulation in Planarians using Chromatin Immunoprecipitation followed by Sequencing (ChIP-seq) -- Assessing Chromatin Accessibility during WBR in Acoels -- Single Cell Transcriptomic Analysis in the Regenerating Cnidarian Nematostella vectensis -- Characterization of Soluble Cell-Free Coelomic Fluid Proteome from the Starfish Marthasterias glacialis -- Using RNA-Sequencing for Transcriptome Profiling of Botrylloides sp. …”
    Link to Metadata
    Electronic eBook
  3. 723

    Organic Chemistry with a Biological Emphasis by Soderberg, Tim

    Published 2016
    Table of Contents: “…Chapter 9: Phosphate transfer reactions -- Section 1: Overview of phosphate groups -- Section 2: Phosphate transfer reactions - an overview -- Section 3: ATP, the principal phosphate group donor -- Section 4: Phosphorylation of alcohols -- Section 5: Phosphorylation of carboxylates -- Section 6: Hydrolysis of organic phosphates -- Section 7: Phosphate diesters in DNA and RNA -- Section 8: The organic chemistry of genetic engineering -- Chapter 10: Nucleophilic carbonyl addition reactions -- Section 1: Nucleophilic additions to aldehydes and ketones: an overview -- Section 2: Hemiacetals, hemiketals, and hydrates -- Section 3: Acetals and ketals -- Section 4: N-glycosidic bonds -- Section 5: Imines -- Section 5: A look ahead: addition of carbon and hydride nucleophiles to carbonyls -- Chapter 11: Nucleophilic acyl substitution reactions -- Section 1: Carboxylic acid derivatives -- Section 2: The nucleophilic acyl substitution mechanism -- Section 3: The relative reactivity of carboxylic acid derivatives -- Section 4: Acyl phosphates -- Section 5: Formation of thioesters, esters, and amides -- Section 6: Hydrolysis of thioesters, esters, and amides -- Section 7: Protein synthesis on the ribosome -- Section 8: Nucleophilic substitution at activated amides and carbamides -- Section 9: Nucleophilic acyl substitution reactions in the laboratory -- Section 10: A look ahead: acyl substitution reactions with a carbanion or hydride ion nucleophile -- Chapter 12: Reactions at the α-carbon, part I -- Section 1: Review of acidity at the α-carbon -- Section 2: Isomerization at the α-carbon -- Section 3: Aldol addition -- Section 4: α-carbon reactions in the synthesis lab - kinetic vs. thermodynamic alkylation products -- Interchapter: Predicting multistep pathways - the retrosynthesis approachChapter 13: Reactions at the α-carbon, part II -- Section 1: Decarboxylation -- Section 2: An overview of fatty acid metabolism -- Section 3: Claisen condensation -- Section 4: Conjugate addition and elimination -- Section 5: Carboxylation -- Chapter 14: Electrophilic reactions -- Section 1: Electrophilic addition to alkenes -- Section 2: Elimination by the E1 mechanism -- Section 3: Electrophilic isomerization -- Section 4: Electrophilic substitution -- Section 5: Carbocation rearrangements -- Chapter 15: Oxidation and reduction reactions -- Section 1: Oxidation and reduction of organic compounds - an overview -- Section 2: Oxidation and reduction in the context of metabolism -- Section 3: Hydrogenation of carbonyl and imine groups -- Section 4: Hydrogenation of alkenes and dehydrogenation of alkanes -- Section 5: Monitoring hydrogenation and dehydrogenation reactions by UV spectroscopy -- Section 6: Redox reactions of thiols and disulfides -- Section 7: Flavin-dependent monooxygenase reactions: hydroxylation, epoxidation, and theBaeyer-Villiger oxidation -- Section 8: Hydrogen peroxide is a harmful 'Reactive Oxygen Species' -- Chapter 16: Radical reactions -- Section 1: Overview of single-electron reactions and free radicals -- Section 2: Radical chain reactions -- Section 3: Useful polymers formed by radical chain reactions -- Section 4: Destruction of the ozone layer by a radical chain reaction -- Section 5: Oxidative damage to cells, vitamin C, and scurvy -- Section 6: Flavin as a one-electron carrier -- Chapter 17: The organic chemistry of vitamins -- Section 1: Pyridoxal phosphate (Vitamin B6) -- Section 2: Thiamine diphosphate (Vitamin B1) -- Section 3: Thiamine diphosphate, lipoamide and the pyruvate dehydrogenase reaction -- Section 4: Folate…”
    Access online version
    Electronic eBook
  4. 724
  5. 725
  6. 726
  7. 727

    Biomineralization From Molecular and Nano-structural Analyses to Environmental Science /

    Published 2018
    Table of Contents: “…-- 37 The Marsh's membrane: a key-role for a forgotten structure -- 38 Pearl production by implantation of outer epithelial cells isolated from the mantle of Pinctada fucata and the effects of blending of epithelial cells with different genetic backgrounds on pearl quality -- 39 Functional analyses of MMP genes in the ligament of Pinctada fucata -- 40 Chitin degraded by chitinolytic enzymes induces crystal defects of calcites -- 41 Screening for genes participating in the formation of prismatic and nacreous layers of the Japanese pearl oyster Pincatada fucata by RNA interference knockdown -- 42 Gene expression patterns in the mantle and pearl sac tissues of the pearl oyster Pinctada fucata -- Part IX Appendix -- 43 Selected SEM and TEM images.…”
    Link to Metadata
    Electronic eBook
  8. 728
  9. 729
  10. 730

    Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension

    Published 2020
    Table of Contents: “…PART I: Basic Science of Pulmonary Development and Pulmonary Arterial Disease -- 1 Perspective for Part I -- 2 The alveolar stem cell niche of the mammalian lung -- 3 Lung development and Notch signalling -- 4 Specialized smooth muscle cell progenitors in pulmonary hypertension -- 5 Diverse Pharmacology of Prostacyclin Mimetics: Implications for Pulmonary Hypertension -- 6 Endothelial-to-mesenchymal transition in pulmonary hypertension -- 7 Extracellular vesicles, MicroRNAs and Pulmonary Hypertension -- 8 Roles of Tbx4 in the lung mesenchyme for airway and vascular development -- 9 A lacZ reporter transgenic mouse line revealing the development of pulmonary artery -- 10 Roles of stem cell antigen-1 in the pulmonary endothelium -- 11 Morphological characterization of pulmonary microvascular disease in bronchopulmonary dysplasia caused by hyperoxia in newborn mice -- 12 Involvement of CXCR4 and stem cells in a rat model of pulmonary arterial hypertension -- 13 Ca2+ signal through inositol trisphosphate receptors for cardiovascular development and pathophysiology of pulmonary arterial hypertension -- PART II: Abnormal pulmonary circulation in the developing lung and heart -- 14 Perspective for Part II -- 15 Pathophysiology of Pulmonary Circulation in Congenital Heart Disease -- 16 Development of Novel Therapies for Pulmonary Hypertension by Clinical Application of Basic Research -- 17 Using Patient-Specific Induced Pluripotent Stem Cells to Understand and Treat Pulmonary Arterial Hypertension -- 18 Modeling pulmonary arterial hypertension using induced pluripotent stem cells -- 19 Dysfunction and restoration of endothelial cell communications in Pulmonary Arterial Hypertension: Therapeutic implications -- 20 Inflammatory Cytokines in the Pathogenesis of Pulmonary Arterial Hypertension -- 21 Genotypes and Phenotypes of Chinese Pediatric Patients with Idiopathic and Heritable Pulmonary Arterial Hypertension- Experiences from A Single Center -- 22 Fundamental Insight into Pulmonary Vascular Disease : Perspectives from Pediatric PAH in Japan -- 23 Risk stratification in paediatric pulmonary arterial hypertension -- 24 The Adaptive Right Ventricle in Eisenmenger Syndrome: Potential Therapeutic Targets for Pulmonary Hypertension -- 25 Impaired right coronary vasodilator function in pulmonary hypertensive rat assessed by in vivo synchrotron microangiography -- 26 Relationship between mutations in ENG and ALK1 gene and the affected organs in hereditary hemorrhagic telangiectasia -- 27 A genetic analysis for patients with pulmonary arterial hypertension -- 28 Evaluation and visualization of right ventricle using three dimensional echocardiography -- 29 Pulmonary hypertension associated with post-operative Tetralogy of Fallot -- 30 Microscopic Lung Airway Abnormality and Pulmonary Vascular Disease Associated with Congenital Systemic to Pulmonary Shunt -- 31 Respiratory syncytial virus infection in infants with heart and lung diseases -- PART III: Ductus arteriosus: bridge over troubled vessels -- 32 Perspective for Part III -- 33 The ductus arteriosus, a vascular outsider, in relation to the pulmonary circulation -- 34 Molecular, genetic, and pharmacological modulation of the ductus arteriosus: KATP channels as novel drug targets -- 35 New mediators in the biology of the ductus arteriosus: Lessons from the chicken embryo -- 36 Constriction of the Ductus Arteriosus with KATP Channel Inhibitors -- 37 New insights on how to treat patent ductus arteriosus -- 38 Antenatal Administration of Betamethasone Contributes to Intimal thickening of the Ductus Arteriosus -- 39 Prostaglandin E-EP4-mediated fibulin-1 up-regulation plays a role in intimal thickening of the ductus arteriosus -- 40 Transcriptional profiles in the chicken ductus arteriosus during hatching -- 41 Inhibition of Cyclooxygenase Contracts Chicken Ductus Arteriosus -- 42 Prostaglandin E2 receptor EP4 inhibition constricts the rat ductus arteriosus -- 43 Dilatation of the Ductus Arteriosus by Diazoxide in Fetal and Neonatal Rats -- 44 The Effect of Long-term Administration of Plostaglandin E1 on Morphological Changes in Ductus Arteriosus -- 45 Significance of SGK1 as a protein kinase transcriptionally regulated by ALK1 signaling in vascular endothelial cells -- 46 Fabrication of Implantable Human Arterial Graft by Periodic Hydrostatic Pressure -- 47 Optimum preparation of Candida albicans cell wall extra (CAWE) for the mouse model of Kawasaki disease -- PART IV: Development and Regeneration of the Cardiovascular System -- 48 Perspective for Part IV -- 49 Advances in the second heart field -- 50 Novel cardiac progenitors for all components of the heart except for the right ventricle -- 51 Regional and TBX5-dependent gene expression in the atria: Implications for pulmonary vein development and atrial fibrillation -- 52 The Endocardium as a Master Regulator of Ventricular Trabeculation -- 53 The Role of Alternative mRNA Splicing in Heart Development -- 54 Progress in the Generation of Multiple Lineage Human-iPSC-derived 3D Engineered Cardiac Tissues for Cardiac Repair -- 55 Quantification of contractility in stem cell derived cardiomyocytes -- 56 A neurotrophic factor receptor GFRA2, a specific surface antigen for cardiac progenitor cells, regulates the process of myocardial compaction -- 57 Cardiac cell specification and differentiation by the defined factors -- 58 A Temporo-Spatial Regulation of Sema3c is Essential for Interaction of Progenitor Cells during Cardiac Outflow Tract Development -- 59 Spatiotemporally restricted developmental alterations in the anterior and secondary heart fields cause distinct conotruncal heart defects -- 60 Significance of transcription factors in the mechanisms of great artery malformations -- 61 The different c-kit expression in human induced pluripotent stem (iPS) cells between with feeder cells and without feeder cells -- 62 Establishment of induced pluripotent stem cells from immortalized B cell lines and their differentiation into cardiomyocytes -- 63 Establishment of an in vitro LQT3 model, using induced pluripotent stem cells from LQT3 patient-derived cardiomyocytes -- 64 Genetic Assessments for clinical courses of Left ventricle noncompaction -- 65 Elucidating the pathogenesis of congenital heart disease in the era of next-generation sequencing.…”
    Link to Metadata
    Electronic eBook
  11. 731
  12. 732
  13. 733
  14. 734